The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
about
SUMOylation-Mediated Regulation of Cell Cycle Progression and CancerThe function, regulation and therapeutic implications of the tumor suppressor protein, PMLPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsHow animal models of leukaemias have already benefited patientsProtein quality control in the nucleusPML is required for telomere stability in non-neoplastic human cellsMultivalent interactions of the SUMO-interaction motifs in RING finger protein 4 determine the specificity for chains of the SUMOThe B-box 1 dimer of human promyelocytic leukemia proteinInternal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic LeDirect inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids.Cardiac Glycosides Activate the Tumor Suppressor and Viral Restriction Factor Promyelocytic Leukemia Protein (PML)Calpain 5 is highly expressed in the central nervous system (CNS), carries dual nuclear localization signals, and is associated with nuclear promyelocytic leukemia protein bodiesControl of antioxidative response by the tumor suppressor protein PML through regulating Nrf2 activity.The role of post-translational modifications in fine-tuning BLM helicase function during DNA repairThe PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrityNuclear domain 10 of the viral aspect.Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway.Identification of RNF168 as a PML nuclear body regulatorPML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.STUbLs in chromatin and genome stability.Role of Signal Regulatory Protein α in Arsenic Trioxide-induced Promyelocytic Leukemia Cell Apoptosis.Neutrophil elastase enhances the proliferation and decreases apoptosis of leukemia cells via activation of PI3K/Akt signaling.Personalized medicine and the clinical laboratory.SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.A novel single cell method to identify the genetic composition at a single nuclear body.Emerging roles of sumoylation in the regulation of actin, microtubules, intermediate filaments, and septinsSynergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.Bayesian network meta-analysis comparing five contemporary treatment strategies for newly diagnosed acute promyelocytic leukaemia.Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.Regulation of transcription factor activity by interconnected post-translational modifications.Topoisomerase II and leukemia.Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.PML Degradation: Multiple Ways to Eliminate PML.Regulation of endothelial cell differentiation and specificationVirion factors that target Daxx to overcome intrinsic immunity.Seeing is believing: visualizing transcriptional dynamics in single cells.PML tumour suppression and beyond: therapeutic implications.Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
P2860
Q26776081-C4A2D6B8-C24E-4829-AD98-07688E60921DQ26779358-74C51F08-71D7-4805-A2DE-4048C27C0F67Q26991440-4250BE9E-646D-4E3C-9476-E1C6B985DBD9Q26997702-60674884-B27F-4D22-8A17-91098CE4D9E3Q27023202-D0EA3A8E-0622-4EF2-B7CF-56D16D03B8F2Q27309962-FD9C3D08-11FF-44BC-8DF2-22DDBA2E7A39Q27680434-9E09D890-792E-4DF8-895F-F09C3DDBA364Q27695779-CF48D757-1893-4E96-B093-0AB9F8FF9485Q27853031-7A34176D-A936-48BC-9BA4-74CB338B0F75Q30278518-EFE5DFA1-4639-4189-B4E9-B42ABA541BD2Q30385919-D7ECE453-C946-4A95-A0D7-1E70C8FF932CQ33888505-48F718DC-2E6A-4451-B186-9B8665CB72E5Q34081454-61B13F84-5046-41B6-B3F3-CD986468336BQ34244028-34AB00BA-FB8D-4F83-80F4-FCA582E1A239Q34350108-9942392D-ED48-470A-A775-6598EAA98BABQ35047491-23C259A8-47CA-4DA1-91D3-C177A3464EEFQ35798939-1470B95C-4A8B-4B56-9286-2334FD976075Q35870845-39F576F2-326C-4A0F-A7AF-091CC34F9193Q36191698-87BE9E44-5F2C-4F92-B2BA-CF17933E8094Q36426331-B75AEECB-B5FA-4E72-9E78-4DEC37BA156BQ36724764-DE64CEA3-DFDC-4C88-9034-12D643991BB2Q36817112-4FB2BABD-A873-4146-B9EF-E516DEE7D23DQ36916966-D5F2C08F-A205-4E88-AD28-F72C4F99982AQ36925532-CDD95AF8-CB1A-4B86-9643-B937856AC555Q37076659-E89F1497-C7CD-4138-ACB1-F89FD8C468DDQ37308644-CBF577EA-DA82-4F7C-9DC1-799B5EBF9919Q37397791-77EDC848-ECC3-43D5-B350-55BF78423559Q37565126-CCF5F8CF-ACB2-40A6-83A8-AEDD3A55E2CBQ37578546-41941BFC-69FB-4F46-8312-3253B965017AQ37638351-5DFB8135-F319-411D-BF49-DD5D89DED410Q37652882-FE82E273-34E7-4C5E-BA89-8C47BBCB4A08Q37712353-1FBC2ACA-C70B-41B6-93E1-500C68CBF8D6Q37721763-D323B72B-FECF-4B54-8942-7D047A8AD282Q38092800-14DD8EE0-C9FF-4CE5-A3D3-7D79428822DBQ38101895-84E42ABA-1D7D-450B-87C8-DD4D80FF267DQ38122355-810E150D-30D5-4D7C-B482-AD39F6AA6519Q38127630-C8A1B193-5ADB-4E91-8FCC-30470A2E0C7CQ38189168-F99B10C7-5A5E-4E5C-ABDA-DE6678FDAE88Q38197273-2A237522-477D-4429-9ED1-A1B3981E373DQ38462168-30B2189D-31C3-43C7-8672-1C23810EB7CB
P2860
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@ast
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@en
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@nl
type
label
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@ast
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@en
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@nl
prefLabel
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@ast
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@en
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@nl
P2860
P921
P3181
P356
P1476
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies
@en
P2093
Valérie Lallemand-Breitenbach
P2860
P3181
P356
10.1083/JCB.201112044
P407
P577
2012-07-09T00:00:00Z